AXIM (AXIM Biotechnologies) DeferredTaxAndRevenue: $0.01 Mil (As of Jun. 2025)


What is AXIM Biotechnologies DeferredTaxAndRevenue?

AXIM Biotechnologies AXIM DeferredTaxAndRevenue is $0.01 Mil as of Jun. 2025. The stock has 7 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

AXIM Biotechnologies's current deferred tax and revenue for the quarter that ended in Jun. 2025 was $0.01 Mil.

AXIM Biotechnologies DeferredTaxAndRevenue Related Terms

AXIM Biotechnologies DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for AXIM Biotechnologies's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AXIM Biotechnologies DeferredTaxAndRevenue Chart

AXIM Biotechnologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.38 0.60 0.73

AXIM Biotechnologies Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.59 0.68 0.73 0.50 0.01
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of $0.01 Mil mean?
AXIM Biotechnologies (AXIM) has a DeferredTaxAndRevenue of $0.01 Mil as of Jun. 2025. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on AXIM Biotechnologies.
Is AXIM Biotechnologies' DeferredTaxAndRevenue too high?
AXIM Biotechnologies' current DeferredTaxAndRevenue is $0.01 Mil.
How does AXIM Biotechnologies' DeferredTaxAndRevenue compare to ZVSA and HEPA?
AXIM Biotechnologies' DeferredTaxAndRevenue of $0.01 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Biotechnology company?
A good DeferredTaxAndRevenue depends on the Biotechnology industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on AXIM Biotechnologies. AXIM Biotechnologies's current DeferredTaxAndRevenue is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AXIM Biotechnologies stock overvalued right now?
AXIM Biotechnologies (AXIM) has a current DeferredTaxAndRevenue of $0.01 Mil. The current DeferredTaxAndRevenue is $0.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For AXIM Biotechnologies (AXIM), the current DeferredTaxAndRevenue is $0.01 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AXIM Biotechnologies Business Description

Address 6048 Cornerstone Court West, Suite E1, San Diego, CA, USA, 92121
AXIM Biotechnologies Inc is a integrated research and development company and developer of diagnostic healthcare solutions serving to enhance the health of people. The company focuses on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, The company owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.